CG Oncology Inc. Common s...

NASDAQ: CGON · Real-Time Price · USD
26.10
0.40 (1.56%)
At close: Aug 18, 2025, 2:53 PM

CG Oncology Common stock Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-88.04M -48.61M -35.44M -12.84M
Depreciation & Amortization
32K 17K 15K 10K
Stock-Based Compensation
11.4M 1.53M 676K 1.11M
Other Working Capital
320K 1.43M 4.46M -2.54M
Other Non-Cash Items
-5.01M -2.06M 509K 30K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
2.91M 3.44M 4.44M -1.97M
Operating Cash Flow
-78.71M -45.68M -29.8M -13.65M
Capital Expenditures
-234K n/a -14K -97K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-1.05B -517.61M -55.34M n/a
Sales Maturities Of Investments
745.41M 396.42M n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
-300.76M -121.19M -55.35M -97K
Debt Repayment
-365K -16.29M n/a 15.2M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-825K n/a n/a n/a
Financial Cash Flow
628.28M 87M 119.69M 15.45M
Net Cash Flow
248.8M -79.88M 34.54M 1.7M
Free Cash Flow
-78.95M -45.68M -29.82M -13.75M